LAH5-mediated delivery of prime editor ribonucleoprotein complexes for genome editing

Publication date

2026-03-10

Authors

Yao, Bing
Öktem, Mert
Yang, Geng
Wang, Qian
Daniels, Mark A.
Dokter, Inge
Lefferts, Juliet W
Gonçalves, Manuel A F V
Doevendans, PieterISNI 0000000110574516
van Mil, AlainORCID 0000-0001-9906-5047ISNI 0000000388487943

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Prime editing (PE) is a precise gene-editing technology with potential for treating genetic disorders, but efficient delivery systems remain a challenge. Viral vectors offer high efficiency but pose safety concerns related with their immunogenicity, while non-viral methods struggle with stability and scalability. Cell-penetrating peptides (CPPs) present a promising alternative due to their low immunogenicity. In this study, we explored LAH5, a histidine-rich CPP, for delivering PE ribonucleoproteins (RNPs) into PLN R14del mutant cell lines. We purified engineered SpGPEmax protein, evaluating its intracellular uptake and editing frequency in HEK293T.PLN R14del reporter cells and human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Our results demonstrate that LAH5 effectively delivers intracellularly SpGPEmax RNP components, resulting in correction of the R14del mutation, thereby offering a viable non-viral strategy for direct cellular precise genome editing.

Keywords

PLN R14del mutation, LAH5, Cardiomyopathy, Endosomalescape, Primeediting, Cell-penetrating peptides, Pharmaceutical Science, Journal Article

Citation

Yao, B, Öktem, M, Yang, G, Wang, Q, Daniels, M A, Dokter, I, Lefferts, J W, Gonçalves, M A F V, Doevendans, P A, van Mil, A, Sluijter, J P G, Schiffelers, R, Mastrobattista, E & Lei, Z 2026, 'LAH5-mediated delivery of prime editor ribonucleoprotein complexes for genome editing', International Journal of Pharmaceutics, vol. 692, 126622. https://doi.org/10.1016/j.ijpharm.2026.126622